GENFLOW BIOSCIENCES PLC
A biotechnology company developing gene therapies that target the aging process.
GENF | IL
Overview
Corporate Details
- ISIN(s):
- GB00BP2C3V08
- LEI:
- 213800HVOFXRXVEGDN62
- Country:
- United Kingdom
- Address:
- 6 HEDDON STREET, W1B 4BT LONDON
- Website:
- https://genflowbio.com/
Description
Genflow Biosciences PLC is a biotechnology company developing gene therapies that target the aging process. The company's primary mission is to slow or halt aging and reduce the incidence of age-related diseases in both humans and dogs, thereby extending healthspan. Its lead therapeutic candidate, GF-1002, is a gene therapy that delivers a centenarian variant of the Sirtuin 6 (SIRT6) gene. This specific gene variant has been identified in individuals who live to 100 years or more and has demonstrated promising results in pre-clinical studies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2026-01-08 08:25 |
Review of 2025
|
English | HTML • 21.3 KB | ||
| 2025-12-16 08:25 |
Completion of Dosing Phase of Canine Gene Therapy
|
English | HTML • 15.7 KB | ||
| 2025-12-11 08:25 |
Genflow to Attend Healthcare Conference
|
English | HTML • 15.1 KB | ||
| 2025-10-31 08:00 |
Total Voting Rights
|
English | HTML • 11.6 KB | ||
| 2025-10-24 08:00 |
Holding(s) in Company
|
English | HTML • 22.0 KB | ||
| 2025-10-22 08:00 |
Second European Patent Application
|
English | HTML • 17.8 KB | ||
| 2025-10-20 08:00 |
Recognition of Patentability of Claims
|
English | HTML • 17.6 KB | ||
| 2025-10-10 08:00 |
Update on Animal Health Program
|
English | HTML • 19.0 KB | ||
| 2025-10-09 08:00 |
Update, Equity Issue and PDMR Notification
|
English | HTML • 35.1 KB | ||
| 2025-10-02 13:37 |
Issue of Equity - Correction
|
English | HTML • 33.2 KB | ||
| 2025-10-02 08:59 |
Issue of Equity
|
English | HTML • 32.5 KB | ||
| 2025-09-30 08:00 |
Half-year Report
|
English | HTML • 227.0 KB | ||
| 2025-09-19 13:40 |
Holding(s) in Company
|
English | HTML • 22.0 KB | ||
| 2025-09-19 08:00 |
Genflow Strengthens IP Portfolio
|
English | HTML • 16.7 KB | ||
| 2025-09-15 08:00 |
Genflow Signs CDAs with Animal Health Companies
|
English | HTML • 17.6 KB |
Automate Your Workflow. Get a real-time feed of all GENFLOW BIOSCIENCES PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GENFLOW BIOSCIENCES PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GENFLOW BIOSCIENCES PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
